Cargando…

The Safety and Efficacy of Ultrasound-Guided Serratus Anterior Plane Block (SAPB) Combined with Dexmedetomidine for Patients Undergoing Video-Assisted Thoracic Surgery (VATS): A Randomized Controlled Trial

BACKGROUND: Although video-assisted thoracic surgery (VATS) can significantly reduce postoperative pain, the incidence is as high as 30–50%. The purpose of this study was to explore the safety and efficacy of ultrasound-guided serratus anterior plane block (SAPB) combined with dexmedetomidine (Dex)...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Xiang, Liu, Yanchao, Zhao, Jing, Xiang, Zhixiong, Ren, Chunguang, Qiao, Kekun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7381820/
https://www.ncbi.nlm.nih.gov/pubmed/32801843
http://dx.doi.org/10.2147/JPR.S258443
_version_ 1783563125947105280
author Li, Xiang
Liu, Yanchao
Zhao, Jing
Xiang, Zhixiong
Ren, Chunguang
Qiao, Kekun
author_facet Li, Xiang
Liu, Yanchao
Zhao, Jing
Xiang, Zhixiong
Ren, Chunguang
Qiao, Kekun
author_sort Li, Xiang
collection PubMed
description BACKGROUND: Although video-assisted thoracic surgery (VATS) can significantly reduce postoperative pain, the incidence is as high as 30–50%. The purpose of this study was to explore the safety and efficacy of ultrasound-guided serratus anterior plane block (SAPB) combined with dexmedetomidine (Dex) for patients undergoing VATS. METHODS: Eighty patients were randomized into two groups (20 mL 0.5% ropivacaine plus 0.5 µg/kg or 1 µg/kg Dex). Primary outcome was the visual analog scale of pain while coughing (VASc) score at 24 h after surgery. Secondary outcomes included hemodynamics, sufentanil consumption, number of patients needing rescue analgesia, time to first rescue analgesic, total dose of rescue analgesic, satisfaction scores of patients and surgeons, time of chest tube removal, length of hospital stay, adverse effects, the prevalence of chronic pain and quality of life. RESULTS: Compared with D1 group, visual analog scale of pain at rest (VASr) was significantly lower during the first 24 h after surgery, while VASc was significantly lower during the first 48 h after surgery (P<0.05). Mean arterial pressure was significantly decreased from T2 to T8, and heart rate was significantly decreased from T2 to T7 in the D2 group (P<0.05). Consumption of sevoflurane, remifentanil, DEX and the recovery time were significantly reduced in the D2 group (P <0.05). Consumption of sufentanil 8–72 h after surgery was significantly lower in the D2 group (P<0.05). Additionally, the number of patients who required rescue analgesia, the time to the first dose of rescue analgesia, and the total dose of rescue analgesia was significantly lower in the D2 group (P<0.05). CONCLUSION: The results of this study show that 1 µg/kg DEX is a beneficial adjuvant to ropivacaine for single-injection SAPB in VATS patients while stable hemodynamics were maintained.
format Online
Article
Text
id pubmed-7381820
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-73818202020-08-13 The Safety and Efficacy of Ultrasound-Guided Serratus Anterior Plane Block (SAPB) Combined with Dexmedetomidine for Patients Undergoing Video-Assisted Thoracic Surgery (VATS): A Randomized Controlled Trial Li, Xiang Liu, Yanchao Zhao, Jing Xiang, Zhixiong Ren, Chunguang Qiao, Kekun J Pain Res Original Research BACKGROUND: Although video-assisted thoracic surgery (VATS) can significantly reduce postoperative pain, the incidence is as high as 30–50%. The purpose of this study was to explore the safety and efficacy of ultrasound-guided serratus anterior plane block (SAPB) combined with dexmedetomidine (Dex) for patients undergoing VATS. METHODS: Eighty patients were randomized into two groups (20 mL 0.5% ropivacaine plus 0.5 µg/kg or 1 µg/kg Dex). Primary outcome was the visual analog scale of pain while coughing (VASc) score at 24 h after surgery. Secondary outcomes included hemodynamics, sufentanil consumption, number of patients needing rescue analgesia, time to first rescue analgesic, total dose of rescue analgesic, satisfaction scores of patients and surgeons, time of chest tube removal, length of hospital stay, adverse effects, the prevalence of chronic pain and quality of life. RESULTS: Compared with D1 group, visual analog scale of pain at rest (VASr) was significantly lower during the first 24 h after surgery, while VASc was significantly lower during the first 48 h after surgery (P<0.05). Mean arterial pressure was significantly decreased from T2 to T8, and heart rate was significantly decreased from T2 to T7 in the D2 group (P<0.05). Consumption of sevoflurane, remifentanil, DEX and the recovery time were significantly reduced in the D2 group (P <0.05). Consumption of sufentanil 8–72 h after surgery was significantly lower in the D2 group (P<0.05). Additionally, the number of patients who required rescue analgesia, the time to the first dose of rescue analgesia, and the total dose of rescue analgesia was significantly lower in the D2 group (P<0.05). CONCLUSION: The results of this study show that 1 µg/kg DEX is a beneficial adjuvant to ropivacaine for single-injection SAPB in VATS patients while stable hemodynamics were maintained. Dove 2020-07-16 /pmc/articles/PMC7381820/ /pubmed/32801843 http://dx.doi.org/10.2147/JPR.S258443 Text en © 2020 Li et al. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Li, Xiang
Liu, Yanchao
Zhao, Jing
Xiang, Zhixiong
Ren, Chunguang
Qiao, Kekun
The Safety and Efficacy of Ultrasound-Guided Serratus Anterior Plane Block (SAPB) Combined with Dexmedetomidine for Patients Undergoing Video-Assisted Thoracic Surgery (VATS): A Randomized Controlled Trial
title The Safety and Efficacy of Ultrasound-Guided Serratus Anterior Plane Block (SAPB) Combined with Dexmedetomidine for Patients Undergoing Video-Assisted Thoracic Surgery (VATS): A Randomized Controlled Trial
title_full The Safety and Efficacy of Ultrasound-Guided Serratus Anterior Plane Block (SAPB) Combined with Dexmedetomidine for Patients Undergoing Video-Assisted Thoracic Surgery (VATS): A Randomized Controlled Trial
title_fullStr The Safety and Efficacy of Ultrasound-Guided Serratus Anterior Plane Block (SAPB) Combined with Dexmedetomidine for Patients Undergoing Video-Assisted Thoracic Surgery (VATS): A Randomized Controlled Trial
title_full_unstemmed The Safety and Efficacy of Ultrasound-Guided Serratus Anterior Plane Block (SAPB) Combined with Dexmedetomidine for Patients Undergoing Video-Assisted Thoracic Surgery (VATS): A Randomized Controlled Trial
title_short The Safety and Efficacy of Ultrasound-Guided Serratus Anterior Plane Block (SAPB) Combined with Dexmedetomidine for Patients Undergoing Video-Assisted Thoracic Surgery (VATS): A Randomized Controlled Trial
title_sort safety and efficacy of ultrasound-guided serratus anterior plane block (sapb) combined with dexmedetomidine for patients undergoing video-assisted thoracic surgery (vats): a randomized controlled trial
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7381820/
https://www.ncbi.nlm.nih.gov/pubmed/32801843
http://dx.doi.org/10.2147/JPR.S258443
work_keys_str_mv AT lixiang thesafetyandefficacyofultrasoundguidedserratusanteriorplaneblocksapbcombinedwithdexmedetomidineforpatientsundergoingvideoassistedthoracicsurgeryvatsarandomizedcontrolledtrial
AT liuyanchao thesafetyandefficacyofultrasoundguidedserratusanteriorplaneblocksapbcombinedwithdexmedetomidineforpatientsundergoingvideoassistedthoracicsurgeryvatsarandomizedcontrolledtrial
AT zhaojing thesafetyandefficacyofultrasoundguidedserratusanteriorplaneblocksapbcombinedwithdexmedetomidineforpatientsundergoingvideoassistedthoracicsurgeryvatsarandomizedcontrolledtrial
AT xiangzhixiong thesafetyandefficacyofultrasoundguidedserratusanteriorplaneblocksapbcombinedwithdexmedetomidineforpatientsundergoingvideoassistedthoracicsurgeryvatsarandomizedcontrolledtrial
AT renchunguang thesafetyandefficacyofultrasoundguidedserratusanteriorplaneblocksapbcombinedwithdexmedetomidineforpatientsundergoingvideoassistedthoracicsurgeryvatsarandomizedcontrolledtrial
AT qiaokekun thesafetyandefficacyofultrasoundguidedserratusanteriorplaneblocksapbcombinedwithdexmedetomidineforpatientsundergoingvideoassistedthoracicsurgeryvatsarandomizedcontrolledtrial
AT lixiang safetyandefficacyofultrasoundguidedserratusanteriorplaneblocksapbcombinedwithdexmedetomidineforpatientsundergoingvideoassistedthoracicsurgeryvatsarandomizedcontrolledtrial
AT liuyanchao safetyandefficacyofultrasoundguidedserratusanteriorplaneblocksapbcombinedwithdexmedetomidineforpatientsundergoingvideoassistedthoracicsurgeryvatsarandomizedcontrolledtrial
AT zhaojing safetyandefficacyofultrasoundguidedserratusanteriorplaneblocksapbcombinedwithdexmedetomidineforpatientsundergoingvideoassistedthoracicsurgeryvatsarandomizedcontrolledtrial
AT xiangzhixiong safetyandefficacyofultrasoundguidedserratusanteriorplaneblocksapbcombinedwithdexmedetomidineforpatientsundergoingvideoassistedthoracicsurgeryvatsarandomizedcontrolledtrial
AT renchunguang safetyandefficacyofultrasoundguidedserratusanteriorplaneblocksapbcombinedwithdexmedetomidineforpatientsundergoingvideoassistedthoracicsurgeryvatsarandomizedcontrolledtrial
AT qiaokekun safetyandefficacyofultrasoundguidedserratusanteriorplaneblocksapbcombinedwithdexmedetomidineforpatientsundergoingvideoassistedthoracicsurgeryvatsarandomizedcontrolledtrial